Electrophysiologic evaluation of a patient with peripheral visual field contraction associated with vigabatrin

Archives of Ophthalmology

Volumn 116, Issue 6, 1998, Pages 817-819

  Ruether, Klaus ^a,b   Pung, Tamara ^a   Kellner, Ulrich ^a   Schmitz, Bettina ^a   Hartmann, Christian ^a   Seeliger, Mathias ^a  

^a Charite Virchow Augenklinik ^*

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; ARTICLE; CASE REPORT; ELECTROPHYSIOLOGY; FOCAL EPILEPSY; HUMAN; MALE; PERIMETRY; PRIORITY JOURNAL; VISUAL FIELD DEFECT;

ADOLESCENT; ANTICONVULSANTS; ELECTRORETINOGRAPHY; EPILEPSIES, PARTIAL; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; RETINA; VALPROIC ACID; VIGABATRIN; VISION DISORDERS; VISUAL FIELDS;

EID: 0031814047     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Bayer AU. Thicl H-J, Zrenner E, Paulus W. Ried S, Schmidt D: Disorders of color perception and increased glare sensitivity in phcnytoin and carbamazepine therapy ocular side effects, of anticonvulsants. Nervenarzt. 1995; 66:89-96.
2. Eke T, Talbot JF, Lawden MC: Severe persistent visual field constriction associated with vig-abatrin [with letters of correspondence appearing in BMJ. 1997;314:1693-1695]. BMJ. 1997; 314:180-181.
3. Graham D. Neuropathology of vigabatrin. Br J Clin Pharmacol 1979;27(suppl 1): 43-53.
4. Seeliger M. Kretschmann U. Apfelstedt-Sylla E. Ruether K, Zrenner C. Mullifocal electroretinography in Retinitis pigmcmosa. Am J Ophthalmol. 1997;125:214-226.
5. Perucca E. The clinical pharmacology of the new antiepileptic drugs. Pharmucol Res. 1993.28;89-106.
6. Kalloniatis M. Amino acids in neurotransmission and disease. J Am Optom Assoc. 1995, 66. 750-757